CN102260225B - 用于抑制肿瘤转移和肿瘤血管生长的苯基哌嗪类衍生物 - Google Patents
用于抑制肿瘤转移和肿瘤血管生长的苯基哌嗪类衍生物 Download PDFInfo
- Publication number
- CN102260225B CN102260225B CN2011101468354A CN201110146835A CN102260225B CN 102260225 B CN102260225 B CN 102260225B CN 2011101468354 A CN2011101468354 A CN 2011101468354A CN 201110146835 A CN201110146835 A CN 201110146835A CN 102260225 B CN102260225 B CN 102260225B
- Authority
- CN
- China
- Prior art keywords
- phenyl
- phenylpiperazine
- acid
- tumor
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (2)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101468354A CN102260225B (zh) | 2011-06-02 | 2011-06-02 | 用于抑制肿瘤转移和肿瘤血管生长的苯基哌嗪类衍生物 |
PCT/CN2012/076384 WO2012163291A1 (zh) | 2011-06-02 | 2012-06-01 | 用于抑制肿瘤转移和肿瘤血管生长的苯基哌嗪类衍生物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101468354A CN102260225B (zh) | 2011-06-02 | 2011-06-02 | 用于抑制肿瘤转移和肿瘤血管生长的苯基哌嗪类衍生物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102260225A CN102260225A (zh) | 2011-11-30 |
CN102260225B true CN102260225B (zh) | 2013-08-21 |
Family
ID=45007091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011101468354A Active CN102260225B (zh) | 2011-06-02 | 2011-06-02 | 用于抑制肿瘤转移和肿瘤血管生长的苯基哌嗪类衍生物 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN102260225B (zh) |
WO (1) | WO2012163291A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102260225B (zh) * | 2011-06-02 | 2013-08-21 | 蒋杰 | 用于抑制肿瘤转移和肿瘤血管生长的苯基哌嗪类衍生物 |
CN103965159B (zh) * | 2014-05-17 | 2017-04-12 | 广州医科大学 | 醚类芳基哌嗪衍生物及其盐、制备方法和用途 |
CN105061352A (zh) * | 2015-07-29 | 2015-11-18 | 广州市广金投资管理有限公司 | 芳基哌嗪衍生物ⅲ及其盐、制备方法和用途 |
CN107879997B (zh) * | 2017-12-25 | 2021-01-26 | 三峡大学 | 一种小分子抑制剂sld1338及其在制药中的应用 |
CN108530391B (zh) * | 2018-05-17 | 2022-05-17 | 袁牧 | 一种酰胺类芳基哌嗪衍生物及其制备方法与应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2922788A (en) * | 1958-05-26 | 1960-01-26 | Parke Davis & Co | Phenylpiperazine compounds and process for producing the same |
DE3139970A1 (de) * | 1981-10-08 | 1983-04-28 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel |
US5518891A (en) * | 1993-03-25 | 1996-05-21 | Actimed Laboratories, Inc. | Dye forming composition and detection of hydrogen peroxide therewith |
JP3940290B2 (ja) * | 2000-12-22 | 2007-07-04 | ザ・ヨルダニアン・フアーマシユーテイカル・エム・エフ・ジー・アンド・メデイカル・イクイツプメント・カンパニー・リミテツド | 新規化合物 |
FR2829766A1 (fr) * | 2001-09-14 | 2003-03-21 | Lipha | Derives d'oxamates comportant un heterocycle azote diversement substitue |
BR0307575A (pt) * | 2002-03-13 | 2004-12-21 | Janssen Pharmaceutica Nv | Derivados de sulfonila como inibidores de histona desacetilase |
NZ536116A (en) * | 2002-04-03 | 2007-01-26 | Topotarget Uk Ltd | Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors |
CA2661538A1 (en) * | 2006-08-24 | 2008-02-28 | Wockhardt Research Centre | Novel macrolides and ketolides having antimicrobial activity |
KR100890633B1 (ko) * | 2007-04-20 | 2009-03-27 | 한국화학연구원 | 세로토닌 수용체에 대한 친화력을 갖는 화합물 |
CN102459209A (zh) * | 2009-04-16 | 2012-05-16 | 武田药品工业株式会社 | 用于预防或治疗糖尿病(等)的n-酰基-n’-苯基哌嗪的衍生物 |
WO2010121212A2 (en) * | 2009-04-17 | 2010-10-21 | H. Lee Moffit Cancer Center And Research Institute, Inc. | Indoline scaffold shp-2 inhibitors and method of treating cancer |
CN102260225B (zh) * | 2011-06-02 | 2013-08-21 | 蒋杰 | 用于抑制肿瘤转移和肿瘤血管生长的苯基哌嗪类衍生物 |
-
2011
- 2011-06-02 CN CN2011101468354A patent/CN102260225B/zh active Active
-
2012
- 2012-06-01 WO PCT/CN2012/076384 patent/WO2012163291A1/zh active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2012163291A1 (zh) | 2012-12-06 |
CN102260225A (zh) | 2011-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002341881B2 (en) | 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors | |
CN102260225B (zh) | 用于抑制肿瘤转移和肿瘤血管生长的苯基哌嗪类衍生物 | |
CA2517256C (en) | Aminoheteroaryl compounds as protein kinase inhibitors | |
CN102884057A (zh) | 雄激素受体调节剂及其用途 | |
CN103804312B (zh) | 一类氮杂环化合物及其制备方法和用途 | |
BRPI0808764B1 (pt) | compostos espiro-substituídos como inibidores de angiogênese seu processo de produção e composição farmacêutica | |
JPWO2013118855A1 (ja) | 複素環および炭素環誘導体 | |
CN102898402B (zh) | 一种苯并异硒唑酮修饰的吡咯甲酸酯取代的吲哚酮类化合物及其应用 | |
CN102149682B (zh) | 1-(取代芳基)-5-三氟甲基-2-(1h)吡啶酮化合物及其盐的制备方法及其用途 | |
TW202115052A (zh) | 芳環或芳雜環類化合物及其製備方法和醫藥用途 | |
JP7181565B2 (ja) | Yap-tead結合を阻害する化合物、およびそれを有効成分として含有する癌の予防または治療用医薬組成物 | |
CN115108999A (zh) | 一种苯基哌嗪喹唑啉类化合物或其药学上可接受的盐、制法与用途 | |
JP2023528637A (ja) | 新規甲状腺ホルモンβ受容体アゴニスト | |
CN102268000A (zh) | 一类新型螺杂环化合物及其作为治疗剂的用途 | |
CN104774221A (zh) | 喹啉酮衍生物的金属配合物及其合成方法及应用 | |
CN104817535A (zh) | 一种喹啉酮衍生物及其合成方法及应用 | |
CN110317173A (zh) | 用作fgfr不可逆抑制剂的酰胺基吡唑类化合物 | |
CN103772352A (zh) | 哒嗪酮类衍生物及其制备方法和用途 | |
CN103864642A (zh) | 大黄酸衍生物及其合成方法和用途 | |
CN105473590A (zh) | 用于治疗增殖性障碍的1h-吡唑并[3,4-b]吡啶衍生物及其药物组合物 | |
CN101560178B (zh) | 一种多取代吲哚啉类化合物、其制备方法及医药用途 | |
CN104725431A (zh) | 喹啉酮衍生物的钴(ⅱ)配合物及其合成方法及应用 | |
WO2021232367A1 (zh) | 3-乙烯基吲唑类衍生物及其制备方法和用途 | |
TWI681960B (zh) | 苯并咪唑類衍生物及其製備方法及其在醫藥上的用途 | |
CN108912035B (zh) | 一种具备抗肿瘤活性的吲哚酰胺类化合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: JIANG FENGCHAO Effective date: 20130718 Owner name: JIANG JIE Free format text: FORMER OWNER: GUANGZHOU HANDING MEDICAL TECHNOLOGY CO., LTD. Effective date: 20130718 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 510632 GUANGZHOU, GUANGDONG PROVINCE TO: 510630 GUANGZHOU, GUANGDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20130718 Address after: 510630 Guangdong city of Guangzhou province Whampoa Tianhe District Avenue, grand villa room 8-1304 Applicant after: Jiang Jie Applicant after: Jiang Fengchao Address before: 510632 Guangdong city of Guangzhou province Tianhe District Tao Yuk Road No. 439 room 82 Applicant before: Guangzhou Handing Medical Technology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |